Antibody Therapeutics Patients First!

공지사항

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 2nd Korean Immuno-Oncology Symposium 2019 March 8th,
  • 글쓴이 관리자
  • 작성일 2019-02-07 09:35:25
  • 조회수 647

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 2nd Korean Immuno-Oncology Symposium 2019 March 8th.

 (http://www.cancer.or.kr/abstract/2019_kios/sche.html).

목록





이전글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
다음글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...